• Sharifa Hasana, Md Farhad Hossain, Maroua Jalouli, Md Tanvir Kabir, Md Giash Uddin, Mir Imam Ibne Wahed, Tapan Behl, May N Bin-Jumah, Mohamed M Abdel-Daim, Lotfi Aleya, and Md Sahab Uddin.
• Department of Pharmacy, Southeast University, Dhaka, Bangladesh.
• Mol. Neurobiol. 2021 May 1; 58 (5): 1917-1931.

AbstractThe new coronavirus (CoV), called novel coronavirus disease 2019 (COVID-19), belongs to the Coronaviridae family which was originated from the sea market in Wuhan city in China, at the end of the year 2019. COVID-19 and severe acute respiratory syndrome (SARS) are belonging to the same family (Coronaviridae). The current outbreak of COVID-19 creates public concern and threats all over the world and now it spreads out to more than 250 countries and territories. The researchers and scientists from all over the world are trying to find out the therapeutic strategies to abate the morbidity and mortality rate of the COVID-19 pandemic. The replication, spreading, and severity of SARS-CoV2 depend on environmental settings. Noteworthy, meteorological parameters are considered as crucial factors that affect respiratory infectious disorders, although the controversial effect of the meteorological parameter is exposed against COVID-19. Besides, COVID-19 accelerates the pathogenesis of the neurological disorders. However, the pathogenic mechanisms between COVID-19 and neurological disorders are still unclear. Hence, this review is focused on the genomics and ecology of SARS-CoV2 and elucidated the effects of climatic factors on the progression of COVID-19. This review also critically finds out the vulnerability between COVID-19 and neurological disorders based on the latest research data.

16 keywords...

hide…